No Detail Found!

Risk Factors Contributing to the Failure of Surfactant Administration with INSURE Method

Author(s)
Manizheh Mostafa Gharehbaghi Professor of Pediatrics and Neonatology, Women's Reproductive Health Research Center, Tabriz University of Medical Sciences,Tabriz,Iran
Ali Peirovifar Associate Professor of Anesthesiology and intensive care, Tabriz University of Medical Sciences,Tabriz,Iran
Morteza Ghojazadeh Associate Professor of Physiology, Tabriz University of Medical Sciences,Tabriz,Iran
Abstract
BACKGROUND: The INSURE method (INtubation- SURfactant- Extubation) is effective in decreasing the need for mechanical ventilation and reducing ventilation-related adverse events. The aim of this study was to determine the risk factors for failure of the INSURE method. METHODS: A prospective descriptive analytical study was conducted in a tertiary level neonatal intensive care unit (NICU) between March 2012 and December 2012. All preterm neonates who received intratracheal surfactant were enrolled in this study and allocated to INSURE failure and INSURE success groups depending on whether they needed intubation and mechanical ventilation or not. RESULTS: Of the 147 neonates, 45 (30.6%) required intubation within the first 72 hours of intratracheal surfactant administration and, therefore, were included in the failure group. The mean birth weight and gestational age in the failure group were 1342±545 grams and 28.7±2.9 week, respectively, and were significantly lower than the success group (1688±472 grams and 31±2.2 week, respectively; p<0.001). The Apgar scores at 1 and 5 minutes were significantly lower in the failure group than the success group (5.7±2.1 and 7.5±1.3 vs. 7.6±1.5 and 8.8±1, respectively; p<0.001). Respiratory distress syndrome (RDS) score was 8.8±1 in the failure group and 7.1±1.3 in the success group (p<0.001). The need for repeated doses of surfactant in the failure group was more than the success group (odds ratio (OR)=8.24, 95% confidence interval (CI): 3.10- 21.86). The patent ductus arteriosus (OR=3.42, 95% CI: 1.46-8.01; p=0.003) and intra ventricular hemorrhage (OR=4.56, 95% CI: 1.90-10.93; p<0.001) were significantly more common in the failure group. CONCLUSION: Preterm infants with lower birth weight and gestational age and higher RDS score are at higher risk of INSURE method failure.
Publication Details
Page(s) 5-9
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 4, Issue: 2, Year: 2014

Request the full text from PASTIC

Keywords
Failure, INSURE method, Surfactant Administration, Preterm infants
References
Angus DC,Linde-Zwirble WT,Clermont G,Griffin MF,Clark RH .2001 .Epidemiology of neonatal respiratory failure in the United States: projections from California. Am J Respir Crit Care Med, 164(7) : 1154-1160.
Fanaroff AA,Stoll BJ,Wright LL,Carlo WA,Ehrenkranz RA,Stark AR .2007 .Trends in neonatal morbidity and mortality for very low birth weight infants. Am J Obstet Gynecol, 196(2) : 149.
Georgy GA,Kitterman JA,Phibbs RH,Tooley WH,Hamilton WK .1971 .Treatment of the idiopathic respiratory distress syndrome with continuous positive airway pressure. N Eng J Med, 284 : 1333-1340.
Cheng-Hwa C .2012 .The role of surfactant in respiratory distress syndrome. The Open Respir Med J, 6 : 44-53.
Fujiwara T,Maeta H,Chida S,Morita T,Watabe Y,Abe T. .1980 .Artificial surfactant therapy in hyalinemembrane disease. Lancet, 12 : 55-59.
Jobe AH,Ikegami M. .2001 .Biology of surfactant. Clin Perinatol, 28(3) : 655-69.
Suresh GK,Soll RF .2003 .Exogenous surfactant therapy in newborn infants. Ann Acad Med Singapore, 32(3) : 335-345.
Burri PH .1984 .Fetal and postnatal development of lung. Ann Rev Physiol, 46)1 : 617-628.
Miller JD,Carlo WA .2008 .Pulmonary complications of mechanical ventilation in neonates. Clin Perinatol, 35(1) : 273-81.
Avery ME,Tooley WH,Keller JB,Hurd SS,Bryan MH,Cotton RB .1987 .Is chronic lung disease in low birth weight infant preventable? A survey of eight centers. Pediaterics, 79(1) : 26-30.
Rojas MA,Lozano JM,Rojas MX,Laughon M,Bose CL,Rondon MA .2009 .Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized controlled trial. Pediatrics, 123(1) : 137-142.
Dani C,Bertini G,Pezzati M,Cecchi A,Caiglioli C,Rubaltelli FF .2004 .Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants < 30 weeks' gestation. Pediatrics, 113(6) : e560-e563.
Gitterman MK,Fusch C,Gittermann AR,Regazzoni BM,Moesinger AC .1996 .Early nasal CPAP treatment reduces the need for intubation in very low birth weight infants. Eur J Pediatr, 156(5) : 384-388.
Ramanathan R .2008 .Optimal ventilatory strategies and surfactant to protect the preterm lungs. Neonatology, 93(4) : 302-308.
Pas AB,Lopriore E,Engbers MJ,Walther FJ .2007 .Early respiratory management of respiratory distress syndrome in very preterm infants and bronchopulmonary dysplasia. PLoS One, 2(2) : e192.
Hutchison AA,Bignall S .2008 .Non-Invasive pressure ventilation in the preterm neonate: reducing endotrauma and the incidence of bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed, 93(1) : F64-F68.
de Winter JP,de Vries MA,Zimmermann LJ. .2010 .Clinical practice: Noninvasive respiratory support in newborns. Eur J Pediatr, 169(7) : 777-782.
Millar D,Kirpalani H .2004 .Benefits of non invasive ventilation. Indian Pediatr, 41(10) : 1008-1017.
Stevens TP,Blennow M,Myers EH,Soll R .2007 .Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev, 4 : CD003063.
Verder H,Bohlin K,Kamper J,Lindwall R,Jonsson B .2009 .Nasal continuous positive airway pressure and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary Dysplasia. Acta Pediatr, 98(9) : 1400-1408.
.2008 .. Neonatology, 93(4) : 309-315.
Andersen T,Holm HS,Kamper J .2006 .Surfactant treatment of newborn infants receiving continuous positive airway pressure treatment. Ugeskr Laeger, 168 : 3723-3727.
Ballard JL,Khory JC,Wedig K,Wang L,EilersWalsman BL,Lipp R .1991 .New Ballard score, expanded to include extremely premature infants. J Pediatr, 119 : 417-423.
Kero PO,Makinen EO .1979 .Comparison between clinical and radiological classification of infants with the respiratory distress syndrome. Eur J Pediatr, 130 : 271-278.
Biarent D. New .1999 .Tools in ventilatory support: high frequency ventilation, nitric oxide, tracheal gas insufflation, non-invasive ventilation. Pediatr Pulmonol Suppl, 18 : 178-181.
Cherif A,Hachani C,Khrouf N C .2008 .Risk factors of the failure of surfactant treatment by transient intubation during nasal continuous positive airway pressure in preterm infants. Am J Peinatol, 25(10) : 647-652.
Dani C,Berti E,Barp J .2010 .Risk factors for INSURE failure in preterm infants. Minerva Pediatr, 62(3 Suppl 1) : 19-20.
0

Citations

0

Downloads

10

Views